1
|
Lee IS, Cho DH, Kim KS, Kim KH, Park J, Kim Y, Jung JH, Kim K, Jung HJ, Jang HJ. Anti-inflammatory effects of embelin in A549 cells and human asthmatic airway epithelial tissues. Immunopharmacol Immunotoxicol 2018; 40:83-90. [PMID: 29299941 DOI: 10.1080/08923973.2017.1414836] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVE Allergic asthma is the most common type in asthma, which is defined as a chronic inflammatory disease of the lung. In this study, we investigated whether embelin (Emb), the major component of Ardisia japonica BL. (AJB), exhibits anti-inflammatory effects on allergic asthma via inhibition of NF-κB activity using A549 cells and asthmatic airway epithelial tissues. METHODS Inflammation was induced in A549 cells, a human airway epithelial cell line, by IL-1β (10 ng/ml) treatment for 4 h. The effects of Emb on NF-κB activity and COX-2 protein expression in inflamed airway epithelial cells and human asthmatic airway epithelial tissues were analyzed via western blot. The secretion levels of NF-κB-mediated cytokines/chemokines, including IL-4, 6, 9, 13, TNF-α and eotaxin, were measured by a multiplex assay. RESULTS Emb significantly blocked NF-κB activity in IL-1β-treated A549 cells and human asthmatic airway epithelial tissues. COX-2 expression was also reduced in both IL-1β-treated A549 cells and asthmatic tissues Emb application. Emb significantly reduced the secretion of IL-4, IL-6 and eotaxin in human asthmatic airway epithelial tissues by inhibiting activity of NF-κB. CONCLUSIONS The results of this study suggest that Emb may be used as an anti-inflammatory agent via inhibition of NF-κB and related cytokines.
Collapse
Affiliation(s)
- In-Seung Lee
- a College of Korean Medicine , Kyung Hee University , Seoul , Republic of Korea.,b Department of Science in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea
| | - Dong-Hyuk Cho
- b Department of Science in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea.,c Department of Biological Sciences in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea
| | - Ki-Suk Kim
- a College of Korean Medicine , Kyung Hee University , Seoul , Republic of Korea
| | - Kang-Hoon Kim
- a College of Korean Medicine , Kyung Hee University , Seoul , Republic of Korea.,b Department of Science in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea
| | - Jiyoung Park
- a College of Korean Medicine , Kyung Hee University , Seoul , Republic of Korea.,b Department of Science in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea
| | - Yumi Kim
- a College of Korean Medicine , Kyung Hee University , Seoul , Republic of Korea.,b Department of Science in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea
| | - Ji Hoon Jung
- a College of Korean Medicine , Kyung Hee University , Seoul , Republic of Korea
| | - Kwanil Kim
- b Department of Science in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea.,c Department of Biological Sciences in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea
| | - Hee-Jae Jung
- b Department of Science in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea.,c Department of Biological Sciences in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea
| | - Hyeung-Jin Jang
- a College of Korean Medicine , Kyung Hee University , Seoul , Republic of Korea.,b Department of Science in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea.,c Department of Biological Sciences in Korean Medicine , Graduate School, Kyung Hee University , Seoul , Republic of Korea
| |
Collapse
|